南京医药 (600713.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(南京医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 13,952,545,044.7953,589,664,728.2040,546,782,609.4227,343,124,491.2614,081,790,518.4550,221,563,813.0337,436,170,395.4223,940,993,596.6011,700,603,929.13
 营业利润(元) 263,541,939.611,007,442,725.13754,693,316.03535,371,744.04252,134,476.28934,322,764.47704,199,881.37476,999,234.84212,662,932.22
 利润总额(元) 262,215,184.52978,068,113.93732,180,279.88521,521,181.46245,043,008.75906,011,909.60682,289,464.99461,468,360.84207,242,030.91
 净利润(元) 196,947,119.74712,808,904.92532,964,478.12375,791,132.31183,605,107.97715,919,570.56555,605,391.39390,134,421.75151,913,357.09
 归属于母公司股东的净利润(元) 159,082,706.83577,825,648.39440,295,384.86308,641,881.41149,157,852.44595,667,803.00470,239,265.45333,218,365.52132,553,759.97
盈利能力:
 销售毛利率(%) 6.036.186.085.995.786.496.306.506.23
 销售净利率(%) 1.411.331.311.371.301.431.481.631.30
 净资产收益率(%) 2.499.297.255.192.51----
 总资产报酬率ROA(%) 1.205.043.522.581.22----
 投入资本回报率ROIC(%) 0.913.862.801.920.954.253.262.310.93
营运能力:
 存货周转率(次) 2.178.687.034.722.31----
 应收账款周转率(次) 0.874.112.581.930.98----
 总资产周转率(次) 0.431.781.260.890.46----
偿债能力:
 资产负债率(%) 77.1074.4678.7279.2078.9978.8579.0176.9177.34
 股东权益比率(%) 20.2722.6518.9518.4618.7818.9618.8320.7020.28
 已获利息倍数(倍) 2.992.832.832.952.943.083.153.283.06
 流动比率 1.411.401.311.371.311.311.261.281.33
 速动比率 1.081.041.031.061.011.001.000.991.00
发展能力:
 营业收入增长率(%) -0.926.718.3114.2120.3511.3012.109.345.56
 营业利润增长率(%) 4.527.837.1712.2418.5610.4819.4425.7031.18
 税后利润增长率(%) 6.65-3.00-6.37-7.3812.5317.9135.7849.8630.01
 净资产增长率(%) 6.977.267.417.288.2630.2531.9932.9031.76
 总资产增长率(%) -0.89-10.246.7120.3016.9422.2715.938.999.37

前瞻产业研究院